Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice

Journal of Neuroimmunology

Volumn 125, Issue 1-2, 2002, Pages 114-124

  Morris Downes, Margaret M ^a,b   Smith, Paul A ^a   Rundle, Jon L ^a   Piddlesden, Sara J ^c   Baker, David ^d   Pham Dinh, Danielle ^e   Heijmans, Nicole ^f   Amor, Sandra ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e SORBONNE UNIVERSITÉ   (France)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Antibodies; Demyelination; Experimental allergic encephalomyelitis; Myelin; Myelin oligodendrocyte glycoprotein

Indexed keywords

COBROTOXIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; MYELIN ANTIBODY; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; IN VIVO STUDY; INFLAMMATION; MALE; MOLECULAR CLONING; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; ONSET AGE; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; REDUCTION; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; COBRA VENOMS; COMPLEMENT SYSTEM PROTEINS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GALACTOSYLCERAMIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; RECURRENCE; SPINAL CORD;

EID: 0036224107     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00040-1     Document Type: Article

References (55)

1. Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis
2. Identification of a major encephalitogenic epitope proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and non-obese diabetic mice
3. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and AB/H mice
4. Encephalitogenic epitopes of myelin basic protein, proteolipid protein and myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif
5. A unique population of circulating autoantibodies promotes central nervous system remyelination
6. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice
7. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases
8. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures
9. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG)
10. A humoral response to oligodendrocyte-specific protein in MS, a potential molecular mimic
11. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
12. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate
13. Identification of autoantibodies associated with myelin damage in multiple sclerosis
14. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis
15. Antibody-dependent cellular cytotoxicity in antimyelin antibody-induced oligodendrocyte damage in vitro
16. Chronic relapsing experimental allergic encephalomyelitis. Immunohistochemical studies
17. Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin
18. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls
19. Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: Identification of a uveitogenic epitope
20. The role of C in viral infections: II. The clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of C
21. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
22. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)
23. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
24. The role of complement in the pathogenesis of experimental allergic encephalomyelitis
25. B cells and antibodies in MS
26. Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: A potential mechanism for the generation of autoantigens
27. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells
28. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin
29. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids
30. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection
31. Receptor-mediated phagocytosis of myelin by macrophages and microglia, effect of opsonization and receptor blocking agents
32. Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis
33. A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg)
34. Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation
35. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
36. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis
37. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
38. Multiple sclerosis: Serum-induced demyelination in vitro. A light and electron microscope study
39. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target
40. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
41. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside
42. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
43. Activated terminal complement in cerebrospinal fluid in Guillain-Barre syndrome and multiple sclerosis
44. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease
45. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis
46. A role for α4-integrin in the pathology following Semliki Forest virus infection
47. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg")
48. Multiple sclerosis-in situ evidence for antibody- and complement-mediated demyelination
49. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls
50. Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig
51. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages
52. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide
53. A randomised trial comparing intravenous immunoglobulin and plasma exchange in Guillian-Barré syndrome
54. Pathogenic autoantibodies to neuronal proteins in neurological disorders
55. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat